I NTRO DUCTI O N
Periodic limb movements during sleep (PLMS) are characterized by highly stereotyped repetitive movements of the limbs, typically the legs, during sleep. Patients may complain of excessive daytime sleepiness (EDS), unrefreshing sleep, nocturnal awakenings and/or insomnia, a condition defined as periodic limb movement disorder (PLMD) according to International Classification of Sleep Disorders, Third Edition (ICSD-3) criteria. 1 The prevalence of PLMS is estimated between 4% to 11% in adults. 2 PLMS are present in nocturnal polysomnography (NPSG) in up to 90% of patients with restless legs syndrome (RLS) and in up to 25% in patients without RLS. 3 PLMS also frequently occur in patients with obstructive sleep apnea (OSA), 4 narcolepsy, 5 rapid eye movement (REM) behavior disorder, 6 and other medical and neurological disorders. 2 Published data suggest that the magnitude of increments of blood pressure during PLMS, especially those associated with electroencephalographic (EEG) arousals, could be on average 22 mmHg for systolic blood pressure and 11 mmHg for diastolic blood pressure, 7 and they have also been associated independently with diastolic blood pressure. 8 Although the relationship between PLMS and hypertension remains unclear, prior large-scale, community-based studies have suggested an association between PLMS and prevalent hypertension, particularly in black men. 9 More convincing evidence exists for a relationship between PLMS and incident cardiovascular disease BRIEF SUMMARY Current Knowledge/Study Rationale: Periodic limb movements during sleep are a relatively common finding in sleep studies and even though not yet established, increasing evidence supports their possible effect on the development of cardiovascular disease. Several markers of large artery stiffness have been linked to cardiovascular disease and have been found to be increased in patients with obstructive sleep apnea. Study Impact: An easily derived marker of the large artery stiffness, produced from the oximetry and accessible to the most sleep centers, was found increased in patients with significant periodic limb movements during sleep and comparable to patients with moderate/ severe obstructive sleep apnea patients and higher in patients with a combination of these two conditions. The SI DVP could potentially serve as an easily derived and widely available in clinical practice marker of large arteries stiffness and further research on the effect of periodic limb movements during sleep on cardiovascular disease through increased arterial stiffness should be undertaken.
in community-dwelling elderly men. 9, 10 Even though causality is far from established, sympathetic overactivity seems the most likely pathophysiological mechanism for CVD development in patients with PLMS.
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Elevated aortic pulse wave velocity (PWV) is considered an independent and major risk factor for cardiovascular disease. 12, 13 Several studies have validated more easily measured markers of large arterial stiffness derived from the digital volume pulse (DVP), 14, 15 either with the utilization of commercial devices or algorithms and in particular the stiffness index derived from DVP (SI DVP ), which has been proposed as a simple, reproducible, and widely available in clinical practice noninvasive measurement of large artery stiffness. 14, 16 OSA is a well-recognized risk factor for CVD and the applicability of noninvasive assessment of large artery stiffness in OSA cohorts has shown great promise. 15, 17 PWV, which is considered a marker of large artery stiffness, has been found to be increased in patients with OSA when compared to age-, body mass index (BMI)-and sex-matched controls. [18] [19] [20] More recently, a number of authors have demonstrated the effectiveness of continuous positive airway pressure (CPAP) treatment in decreasing the arterial stiffness derived either from PWV or DVP in subjects with OSA. 15, 17, 21, 22 In this retrospective study, we aimed to generate from oximetry recordings and measure the nocturnal SI DVP in patients with PLMS and compare with age-and BMI-matched controls. As a secondary objective, we compared the SI DVP between patients with OSA or PLMS or a combination of these conditions.
M ETHO DS

Patient Selection
Male patients older than 18 y who underwent NPSG between January 2011 and July 2014 at Guy's and St Thomas' Sleep Disorders Centre were retrospectively assessed. Subjects with an apnea-hypopnea index (AHI) > 10 events/h, and those with a periodic limb movement index (PLMI) > 15 events/h were considered for inclusion. To avoid known sex-related effects on arterial stiffness, only male subjects were eventually included in the study. 23 Exclusion criteria were the presence of CVD diagnosis, diabetes mellitus, hypercholesterolemia, arrhythmias, or administration of vasoactive medications (e.g., antihypertensive drugs, hormone replacement therapy, antidiabetes drugs) until the date of the sleep study and based on patients' clinical records. All patients had recent blood pressure measurements within normal range (systolic blood pressure: 110 ± 8 mmHg [range: 129-99 mmHg], diastolic blood pressure: 71 ± 6 mmHg [range: 68-80 mmHg]. Smokers or ex-smokers and patients who had previously received a diagnosis or treatment for sleep disorders, including RLS, were also excluded from the study. A group of age-matched subjects with no exclusion criteria and who were initially assessed for slow wave sleep arousal disorder and who finally did not show any evidence of sleep disorders on NPSG, served as the control group.
Sleep Study Methodology
The NPSG was performed using the standard EEG montage and the sleep stages were scored using 30-sec epochs according to standard criteria by the American Academy of Sleep Medicine. Continuous recordings included electro-oculography, electrocardiography, submental and leg electromyography, pulse oximetry, and nasal cannula and respiratory inductance plethysmography with chest and abdominal belts. 24 Patients were subsequently reviewed with the results of the NPSG and the diagnoses of OSA, PLMS, OSA/PLMS were made in accordance with ICSD-3 criteria 1 using as cutoffs for OSA an AHI > 10/h and for PLMS a PLMI > 15/h. The PLMI was defined as the total number of periodic leg movements per hour of sleep. Leg movements after respiratory events were excluded. An obstructive apneic event was scored if at least 90% reduction of the airflow signal compared to that preceding was observed lasting ≥ 10 sec with current thoracoabdominal movements, and hypopnea was scored when a reduction of the airflow ≥ 50% was present lasting ≥ 10 sec associated with either an arousal or a desaturation of ≥ 3%.
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All NPSGs were analyzed and several variables were derived for further examination: AHI, PLMI, SI DVP , and total arousal index (AI) composed of respiratory-related arousal index, periodic limb movement AI, spontaneous AI, and major body movements.
The SI DVP was measured by transmission of the infrared light through the finger pulp (photoplethysmography) of the index finger, generated from the conventional pulse oximeter trace of the already recorded NPSGs. The contour of the DVP exhibits an early systolic peak and a later peak or point of inflection, as a result of a complex interaction between the left ventricle and the systemic circulation. The first peak is considered to be a result of pressure transmitted along a direct path from the left ventricle to the finger, and the second peak is formed partly by pressure transmitted along the aorta and large arteries to sites of increased resistance in the lower body, where it is reflected back up the aorta. The equation used for SI DVP equals the height of the patient (h) divided by the transit time taken for pressure to propagate from the aorta to the lower body and then reflected back to the root of the subclavian artery (ΔΤ DVP ); which is the difference between the first and second peak (SI DVP = h / ΔΤ DVP ).
14,25 The SI DVP for all patients was measured blindly to clinical diagnosis, for 2 min prior to sleep onset, for 2 min every half an hour after sleep onset, and in the morning after completion of the study while the patient lay relaxed without external stimuli.
The protocol was approved by Guy's and St. Thomas' Hospital Research Ethics Committee. 
Statistical Analysis
RESULTS
From the 880 subjects who underwent NPSG at Guy's and St. Thomas' Sleep Disorders Centre between January 2011 and July 2014 and received a diagnosis of one of the four included diagnoses in this study, only 49 male subjects were finally eligible for further analysis and generation of the oximetry derived SI DVP. The majority of the excluded patients had a concomitant clinical diagnosis and/or other sleep disorders included in the exclusion criteria (46%) or were current or ex-smokers (28%) (Figure 1) . To avoid known sex influence on arterial stiffness, 31 female subjects were excluded from the remaining 80 eligible patients, and the males were categorized as follows: 8 were included in the control group, 13 in the PLMS, 17 in the OSA and another 11 in the OSA/PLMS group. Demographics and sleep variables of these subjects are presented in Table 1 .
Groups were similar in terms of age and BMI, and PLMI and AHI indices did not differ significantly, where appropriate, between OSA/PLMS, PLMS and OSA groups (p < 0.05, Table 1 ). Control subjects, as expected, showed the lowest mean for all the predetermined overnight measurements of SI DVP (5.52 ± 0.3 m/sec) compared to PLMS, OSA and OSA/PLMS (6.78 ± 0.3, 6.94 ± 0.1, 7.40 ± 0.2 m/sec, p < 0.001), whereas the OSA/PLMS group demonstrated the highest (p < 0.001) (Figure 2) . Patients with PLMS and OSA showed comparable overall SI DVP (6.78 ± 0.3 versus 6.94 ± 0.1 m/sec, p = 0.5). Similar results were seen when the mean SI DVP at baseline and in the morning was compared between groups, except that morning measurements in the OSA group was higher compared to PLMS (7.27 ± 1.5 versus 6.82 ± 0.9, p = 0.032). (Figure 2 ) Only the control group demonstrated a lower morning arterial stiffness compared to its baseline measurements (5.39 ± 0.6 versus 6.20 ± 0.50, p = 0.008); the PLMS showed no significant decrement (6.88 ± 0.9 versus 6.90 ± 0.8).
The rest of the two groups showed a tendency for an increased SI DVP in the morning compared to baseline but not statistical significant (OSA, 7.46 ± 1.4 versus 7.26 ± 1.5; OSA/PLMS, 7.74 ± 1.1 versus 7.36 ± 1.1) (Figure 3) .
To better understand the influence of sleep stage on arterial stiffness, the SI DVP per sleep stage for each group was calculated. Within-group analysis revealed that in the control group the mean SI DVP in sleep stage 1 (N1) was lower compared to other sleep stages (p < 0.001) ( Table 2) , whereas in patient groups the mean SI DVP during N1 was higher compared to REM (p < 0.05) (Table 3, Figure 4) .
The control group also had the lowest SI DVP per sleep stage when compared to the patient groups (p < 0.001). The OSA/ PLMS group had the highest arterial stiffness in sleep stage 2 (N2), sleep stage 3 (N3) and REM (p < 0.001) and comparable with the OSA group in wake (W) and N1 (p = 0.09 and p = 0.5 respectively) (Table 3, Figure 4 ).
DISCUSSI ON
Although the hypothesis that PLMS may be a possible risk factor for CVD was raised several years ago, 26 only recently have larger studies demonstrated a positive association. 8, 9, 11, 27 Although conventional methods of measuring large artery stiffness would not be applicable during an overnight sleep study, new validated methods provide this option. SI DVP derived from photoplethysmography shares the same principles as pulse oximetry, allowing for overnight analysis in patients with various sleep conditions. 14, 28 OSA is already considered an important contributory factor in CVD, 29 and increased arterial stiffness in patients with OSA has already been demonstrated. 9, 30 To our knowledge, this is the first study to examine arterial stiffness in patients with PLMS, and to compare this relationship with arterial stiffness in OSA. In this study, patients with significant PLMS exhibited an increased SI DVP compared to controls, comparable to patients with moderate to severe OSA, whereas the OSA/PLMS group exhibited the highest SI DVP , implying a possible additive role of the two conditions in driving endothelial dysfunction.
Sympathetic activation remains the most likely pathophysiological mechanism through which PLMS lead to CVD.
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PLMS are associated with significant rises in pulse rate and
Figure 3-SI
DVP for the four groups averaged for 2 min before (baseline), at the end (morning) and every half hour after sleep onset during the sleep study.
Data are presented as mean ± standard error of the mean. *p < 0.05 for SI DVP morning versus SI DVP baseline . transient increases in blood pressure which, in the long term, may lead to hypertension, heart disease, and stroke. 7, 27 A 10-to 20-mmHg elevation in blood pressure and 10 beats per minute (bpm) increase in heart rate have been associated with limb movements comprising PLMS. 7, 27 A recent observational study by Koo et al. 9 demonstrated that the frequency of PLMS is associated with incident cardiovascular disease in elderly men. The Multi-Ethnic Study of Atherosclerosis (MESA) concluded that OSA is a risk marker for increased blood pressure, whereas limb movements with arousals were independently associated with increased diastolic blood pressure. 8 In the current study, patients with significant PLMS had higher arterial stiffness at baseline, overnight, and in the morning, compared to ageand BMI-matched controls, and were generally comparable to those of patients with moderate/severe OSA. These findings may reflect the importance of PLMS in the development of CVD but also the applicability of using a validated marker of large artery stiffness, SI DVP , in large-scale studies through conventional pulse oximetry recordings, even without the utilization of commercial devices or sophisticated algorithms.
The comparable results of SI DVP between PLMS and OSA raises the question of whether PLMS are as important as OSA from a CVD perspective. Data are emerging that assess PLMS and hypertension but still research of greater scale is required. Furthermore, large prospective studies have demonstrated that nocturnal blood pressure is a better predictor of CVD risk than daytime blood pressure, 31 emphasizing the need for further studies to be undertaken regarding PLMS as a possible risk factor for CVD.
The OSA/PLMS group demonstrated the highest SI DVP compared to PLMS and OSA groups. An additive role of the two conditions for the increased arterial stiffness is conceivable, with, a recent study demonstrating that PLMS in patients with OSA is associated with increased systemic inflammation and fibrinogen levels, both predictive factors for future cardiovascular events. 32 As PLMS tend to be frequent in patients with OSA, a more detailed analysis of this hypothesized additive effect on CVD should be considered.
We found a significant influence of sleep stage on the SI DVP , both in controls and in patient groups. Although in controls the lowest arterial stiffness was in N1, in the patient groups N3 and REM demonstrated the lowest arterial stiffness. Previous studies have shown that there is a downregulation of the sympathoadrenal and noradrenergic branches of the sympathetic nervous system with significant decrease of catecholamine concentration from N1 to REM sleep. 33, 34 However, increased muscle sympathetic activity, blood pressure, and heart rate during REM have also been demonstrated implying a complex orchestration of autonomic nervous system functionality. 35 Our patients' results are in line with previous analysis in patients with OSA, 15 and suggest a complicated dysregulation of the sympathetic nervous system as a result of these sleep disorders.
Limitations
By its retrospective nature, and the strict exclusion criteria applied, we recognize the major limitation of this study as small sample size, and clearly the findings of this pilot study need to be replicated in larger prospective cohorts, which would allow further correlation analysis of arousals (respiratory and leg related) with SI DVP . Excluding female subjects due to known effects on arterial stiffness is another limitation and future matched for sex studies would be recommended. That was a sleep laboratory-based study and future community-based enrollment would be advisable. This analysis is cross-sectional in nature and as such, inferences to causality cannot be made.
CO NCLUSI O N
In this study, utilizing a validated contour analysis of the DVP, which is easily derived from the oximetry recordings and widely available in clinical practice, we have demonstrated that the arterial stiffness index in patients with significant PLMS is increased compared to controls, comparable to patients with moderate to severe OSA, whereas a possible additive impact of PLMS on arterial stiffness in patients with OSA was also identified . Establishing the clinical relevance of these findings will require larger, prospective studies.
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